Pure Bioscience Inc Revenue Growth Rates (PURE), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Pure Bioscience Inc   (PURE)
 

PURE's Revenue Growth by Quarter and Year

Pure Bioscience Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PURE Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter July -
3rd Quarter April 0.51
2nd Quarter January 0.44
1st Quarter October 0.71
FY 1.66

PUREs Annual Revenue
Pure Bioscience Inc 's Revenue in the fiscal year 2025 $ 2.20 millions
Pure Bioscience Inc 's Revenue in the fiscal year 2024 $ 1.96 millions
Pure Bioscience Inc 's Revenue in the fiscal year 2023 $ 1.88 millions
Pure Bioscience Inc 's Revenue in the fiscal year 2022 $ 1.85 millions
Pure Bioscience Inc 's Revenue in the fiscal year 2021 $ 3.93 millions




PURE Revenue third quarter 2026 Y/Y Growth Comment
Pure Bioscience Inc reported Revenue growth of 3.27% year on year in the third quarter 2026, to $ 0.51 millions, this is lower than Pure Bioscience Inc 's recent average Revenue rise of 53.33%.

Looking into third quarter 2026 results within Chemical Manufacturing industry 31 other companies have achieved higher Revenue growth. While Pure Bioscience Inc ' s Revenue increase of 3.27% ranks overall at the positon no. 2315 in the third quarter 2026.


PURE Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter July - 61.7 % -21.67 % 46.34 %
3rd Quarter April 3.27 % 11.36 % 7.32 % -21.15 %
2nd Quarter January 12.82 % 18.18 % -17.5 % -4.76 %
1st Quarter October 26.79 % -22.22 % 53.19 % -6 %
FY   - 12.24 % 4.26 % -

Financial Statements
Pure Bioscience Inc 's third quarter 2026 Revenue $ 0.51 millions PURE's Income Statement
Pure Bioscience Inc 's third quarter 2025 Revenue $ 0.49 millions Quarterly PURE's Income Statement


PURE Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter July - 55.1 % 6.82 % 46.34 %
3rd Quarter April 15 % 25.64 % 33.33 % 2.5 %
2nd Quarter January -38.03 % -30.36 % -54.17 % -14.89 %
1st Quarter October -6.58 % 19.15 % 20 % 14.63 %
FY (Year on Year)   - 12.24 % 4.26 % -


Back to PURE Growth rate Comparisons >> Back to PURE Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Chemical Manufacturing Industry #32
Basic Materials Sector #130
Overall #2315

Revenue Y/Y Growth Statistics
High Average Low
611.86 % 53.33 % -84.41 %
(Jul 31 2020)   (Jul 31 2022)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Chemical Manufacturing Industry #32
Basic Materials Sector #130
Overall #2315
Revenue Y/Y Growth Statistics
High Average Low
611.86 % 53.33 % -84.41 %
(Jul 31 2020)   (Jul 31 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Pure Bioscience Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
536.59 % 22.58 % -100 %
(Apr 30 2014)  


PURE's III. Quarter Q/Q Revenue Comment
Pure Bioscience Inc achieved in the III. Quarter 2026 below company average Revenue rise of 15% quarter on quarter, to $ 0.51 millions.

Within Chemical Manufacturing industry 13 other companies have achieved higher Revenue quarter on quarter growth. While Pure Bioscience Inc 's Revenue growth quarter on quarter, overall rank is 582.


Revenue Q/Q Growth Company Ranking
Within: No.
Chemical Manufacturing Industry #14
Basic Materials Sector #44
Overall #582
Revenue Q/Q Growth Company Ranking
Within: No.
Chemical Manufacturing Industry #14
Basic Materials Sector #44
Overall #582
Revenue Q/Q Growth Statistics
High Average Low
536.59 % 22.58 % -100 %
(Apr 30 2014)  


PURE's III. Quarter Q/Q Revenue Comment
Pure Bioscience Inc achieved in the III. Quarter 2026 below company average Revenue rise of 15% quarter on quarter, to $ 0.51 millions.

Within Chemical Manufacturing industry 13 other companies have achieved higher Revenue quarter on quarter growth. While Pure Bioscience Inc 's Revenue growth quarter on quarter, overall rank is 582.


Pure Bioscience Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Apr 30 2026)		 12 Months Ending
(Jan 31 2026)		 12 Months Ending
(Oct 31 2025)		 12 Months Ending
(Jul 31 2025)		 12 Months Ending
(Apr 30 2025)
Cumulative Revenue 12 Months Ending $ 2.42 $ 2.41 $ 2.35 $ 2.20 $ 1.91
Y / Y Revenue Growth (TTM) 26.67 % 29.27 % 31 % 12.18 % -8.56 %
Year on Year Revenue Growth Overall Ranking # 2813 # 2726 # 2899 # 1596 # 480
Seqeuential Revenue Change (TTM) 0.62 % 2.25 % 6.9 % 15.17 % 2.69 %
Seq. Revenue Growth (TTM) Overall Ranking # 2080 # 1823 # 2703 # 2535 # 1915


Cumulative Revenue growth Comment
Assuming the Pure Bioscience Inc 's fiscal year would have ended in Apr 30 2026, Pure Bioscience Inc would have reprted above average annual Revenue rise of 26.67% year on year, of $ 2 millions.
This marks a slow-down of the companys growth trends and from the 29.27% improvement in Jan 31 2026.

In the Basic Materials sector 172 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2726 to 2813.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Chemical Manufacturing Industry # 30
Basic Materials Sector # 173
Overall # 2813

Revenue TTM Y/Y Growth Statistics
High Average Low
262.34 %
 21.2 %
-52.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 117
S&P 500 # 2080
Cumulative Revenue growth Comment
Assuming the Pure Bioscience Inc 's fiscal year would have ended in Apr 30 2026, Pure Bioscience Inc would have reprted above average annual Revenue rise of 26.67% year on year, of $ 2 millions.
This marks a slow-down of the companys growth trends and from the 29.27% improvement in Jan 31 2026.

In the Basic Materials sector 172 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2726 to 2813.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Chemical Manufacturing Industry # 30
Basic Materials Sector # 173
Overall # 2813

Revenue TTM Y/Y Growth Statistics
High Average Low
262.34 %
21.2 %
-52.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 30
Sector # 117
S&P 500 # 2080




Other Revenue Growth
Chemical Manufacturing Industry Revenue Growth Trends and Statistics
Basic Materials Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PURE's Revenue Growth Ratio versus Chemical Manufacturing Industry, Basic Materials Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue improvement for the quarter ending Apr 30 2026 within Basic Materials SectorY/Y Change %Revenue for the quarter ending Apr 30 2026
Pure Bioscience Inc 3.05%$ 3.055 millions
Quanex Building Products Corporation2.19%$ 2.186 millions


About Pure Bioscience Inc Revenue Growth Rates (PURE), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Pure Bioscience Inc (CIK 1006028).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-028691
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Pure Bioscience Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.